Search research articles
Contact Us
Filters
Showing results (111-120 of 139) with videos related to
Page
of 14
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 4, 2018
Applying the QUARTZ Trial Results in Clinical Practice: Development of a Prognostic Model Predicting Poor Outcomes for Non-small Cell Lung Cancers with Brain Metastases
J P Agarwal, S Chakraborty, S G Laskar, et al.
British Journal of Cancer
|
August 14, 2014
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
A Choughule, R Sharma, V Trivedi, et al.
ISRN Oncology
|
October 11, 2013
Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?
V Patil, V Noronha, A Joshi, et al.
Oncotargets and Therapy
|
January 23, 2015
Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung
Dc Doval, K Prabhash, S Patil, et al.
Cancer Treatment and Research Communications
|
December 18, 2020
Evolving multidisciplinary treatment of squamous cell carcinoma of the head and neck in India<sup>✰</sup>
A K Anand, J P Agarwal, A D'Cruz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2023
Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy
I F Tannock, G Bouche, D A Goldstein, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 16, 2024
Contralateral Nodal Relapse in Well-lateralised Oral Cavity Cancers Treated Uniformly with Ipsilateral Surgery and Adjuvant Radiotherapy With or Without Concurrent Chemotherapy: a Retrospective Study
M Swain, A Budrukkar, V Murthy, et al.
Indian Journal of Cancer
|
December 5, 2017
A comparative analysis of immunohistochemistry and fluorescent <i>in situ</i> hybridization assay to detect anaplastic lymphoma kinase status in lung adenocarcinoma cases: A search for a testing algorithm
P B Wagle, N A Jambhekar, R Kumar, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 19, 2023
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer
V Murthy, P Maitre, M Singh, et al.
Oral Oncology
|
August 19, 2014
Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers
V M Patil, K Prabhash, V Noronha, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 139) with videos related to
Sort By:
Page
of 14
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 4, 2018
Applying the QUARTZ Trial Results in Clinical Practice: Development of a Prognostic Model Predicting Poor Outcomes for Non-small Cell Lung Cancers with Brain Metastases
J P Agarwal, S Chakraborty, S G Laskar, et al.
British Journal of Cancer
|
August 14, 2014
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
A Choughule, R Sharma, V Trivedi, et al.
ISRN Oncology
|
October 11, 2013
Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?
V Patil, V Noronha, A Joshi, et al.
Oncotargets and Therapy
|
January 23, 2015
Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung
Dc Doval, K Prabhash, S Patil, et al.
Cancer Treatment and Research Communications
|
December 18, 2020
Evolving multidisciplinary treatment of squamous cell carcinoma of the head and neck in India<sup>✰</sup>
A K Anand, J P Agarwal, A D'Cruz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2023
Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy
I F Tannock, G Bouche, D A Goldstein, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 16, 2024
Contralateral Nodal Relapse in Well-lateralised Oral Cavity Cancers Treated Uniformly with Ipsilateral Surgery and Adjuvant Radiotherapy With or Without Concurrent Chemotherapy: a Retrospective Study
M Swain, A Budrukkar, V Murthy, et al.
Indian Journal of Cancer
|
December 5, 2017
A comparative analysis of immunohistochemistry and fluorescent <i>in situ</i> hybridization assay to detect anaplastic lymphoma kinase status in lung adenocarcinoma cases: A search for a testing algorithm
P B Wagle, N A Jambhekar, R Kumar, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 19, 2023
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer
V Murthy, P Maitre, M Singh, et al.
Oral Oncology
|
August 19, 2014
Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers
V M Patil, K Prabhash, V Noronha, et al.
Page
of 14